Skip to content

STENAPHAR

Absorbed by MULTIPHARMA on 12-06-2025 KBO/BCE: BE 0467.037.380

Timeline

38 events since 1999
2025
Merger: absorbed by MULTIPHARMADissolution of the company · Dissolved without liquidation · MULTIPHARMA holds all the shares4 points ▸
  • MULTIPHARMA holds all the shares
  • The operation takes effect in the accounts on 01-01-2025
  • Discharge granted to (sole director)
  • Power of attorney granted to
  • The deed holds 11 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2024 filed PDFfull format · 38 days before the deadline
Merger proposal: to be absorbed by MULTIPHARMA2 points ▸
  • Merger by absorption
  • The operation takes effect in the accounts on 01-01-2025
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

Powers of attorney granted to , and 5 others is in office as director · Board meeting of 04-02-20258 points ▸
  • Board meeting of 04-02-2025
  • Power of attorney granted to
  • Power of attorney granted to
  • Power of attorney granted to
  • Power of attorney granted to
  • Power of attorney granted to
  • Power of attorney granted to
  • Power of attorney granted to

Open the deed in the Belgian Official Gazette

2024
Back to profit net €99,140 The net result is €99,140, after one loss-making year.
Equity above €150,000 equity €199,242 ▲99% Equity rises from €100,102 to €199,242.
Annual accounts 2023 filed PDFfull format · 7 days before the deadline
Registered-office move1 point ▸
  • The registered office moved to Square Marie Curie 30, 1070Anderlecht
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

changes role from manager to directorDischarge granted to · General meeting of 12-12-20237 points ▸
  • General meeting of 12-12-2023
  • The capital is divided into 750 shares
  • appointed as director, not named in the articles
  • resigns as manager
  • Discharge granted to
  • The registered office is at rue du Centre 29, 4000 Liège-Sclessin
  • Power of attorney granted to
  • The deed holds 4 more points.

Open the deed in the Belgian Official Gazette

1 director appointed, 1 statutory auditor appointed, 1 resignation resigns · and (statutory auditor) appointed · acts as permanent representative · General meeting of 20-12-202313 points ▸
  • General meeting of 20-12-2023
  • resigns as director
  • appointed as director
  • appointed as statutory auditor
  • acts as permanent representative
  • Board meeting of 20-12-2023
  • Power of attorney granted to (proxy holder)
  • Power of attorney granted to (proxy holder)
  • Power of attorney granted to (proxy holder)
  • Power of attorney granted to (proxy holder)
  • Power of attorney granted to (proxy holder)
  • Power of attorney granted to (proxy holder)
  • Power of attorney granted to (proxy holder)

Open the deed in the Belgian Official Gazette

2023
Annual accounts 2022 filed PDFmicro format · 32 days late
2022
Back to profit net €3,229 The net result is €3,229, after one loss-making year.
Annual accounts 2021 filed PDFmicro format · 31 days late
2021
Annual accounts 2020 filed PDFfull format · 31 days late
2020
Annual accounts 2019 filed PDFfull format · 101 days late
2019
Annual accounts 2018 filed PDFfull format · 29 days late
2018
Annual accounts 2017 filed PDFfull format · 31 days late
2017
Annual accounts 2016 filed PDFfull format · 31 days late
2016
Equity above €100,000 equity €102,306 ▲10.4% After 8 profitable years in a row, equity reaches €102,306.
Annual accounts 2015 filed PDFfull format · 31 days late
2015
Annual accounts 2014 filed PDFfull format · 31 days late
2014
Annual accounts 2013 filed PDFfull format · 30 days late
2013
Annual accounts 2012 filed PDFfull format · 61 days late
2012
Annual accounts 2011 filed PDFfull format · 31 days late
2011
Annual accounts 2010 filed PDFfull format · 31 days late
2010
Annual accounts 2009 filed PDFfull format · 31 days late
2009
Back to profit net €15,819 The net result is €15,819, after one loss-making year.
Annual accounts 2008 filed PDFfull format · 153 days late
2008
Weakest financial year net -€14,893 The net result drops to -€14,893, the lowest from 2007 to 2024.
Annual accounts 2007 filed PDFfull format · 29 days late
2007
Annual accounts 2006 filed PDFfull format · 31 days late
2006
Annual accounts 2005 filed PDFfull format
2005
Annual accounts 2004 filed PDFfull format
Annual accounts 2003 filed PDFfull format
2003
Annual accounts 2002 filed PDFfull format
2002
Annual accounts 2001 filed PDFfull format
2001
Annual accounts 2000 filed PDFfull format
1999
Incorporation 16 publications in the Belgian Official Gazette, the last on 24-06-2025

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

is director of STENAPHAR, appointed by deed of 08-02-2024.1 The company has filed 25 sets of annual accounts, the latest for financial year 2024.2 In 2025 the company was absorbed by merger into MULTIPHARMA.3

  1. 1Belgian Official Gazette, 08-02-2024
  2. 2National Bank, annual accounts 2024
  3. 3Belgian Official Gazette, 24-06-2025